Oruka Therapeutics, Inc.

ORKA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000907654

SEC filings (opens in a new tab)

In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 15 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Oruka Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of ORKA: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Q4 2024	Change
Holders	42	66	+24
Shares	24.6M	31.0M	+6.48M (+26.4%)
Value	$604.2M	$606.6M	+$2.45M (+0.4%)

New holders (29)

Institutions that held Oruka Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ORKA in Q4 2024
Institution	Shares	Value	% of portfolio
Polar Capital Holdings Plc	550,000	$10.7M	0.06%
Jefferies Financial Group Inc.	350,029	$6.79M	0.08%
Blackstone Group Inc.	240,174	$4.66M	0.02%
Barclays PLC	74,583	$1.45M	0.00%
Northern Trust Corp	64,044	$1.24M	0.00%
Kennedy Capital Management, Inc.	60,494	$1.17M	0.03%
Toronto Dominion Bank	58,332	$1.13M	0.00%
Weiss Asset Management LP	40,000	$775.6K	0.02%
683 Capital Management, LLC	33,875	$656.8K	0.06%
Millennium Management LLC	30,305	$587.6K	0.00%
UBS Group AG	25,162	$487.9K	0.00%
State Street Corp	25,023	$485.2K	0.00%
Allostery Investments LP	20,000	$387.8K	0.76%
B Group, Inc.	20,000	$387.8K	0.24%
Omers Administration Corp	19,800	$383.9K	0.00%
Jane Street Group, LLC	17,706	$343.3K	0.00%
Charles Schwab Investment Management Inc	15,608	$302.6K	0.00%
Squarepoint Ops LLC	12,175	$236.1K	0.00%
China Universal Asset Management Co., Ltd.	7,421	$143.9K	0.01%
AlphaCentric Advisors LLC	6,140	$119.1K	0.12%
JPMorgan Chase & Co	2,800	$54.3K	0.00%
Mirae Asset Global Investments Co., Ltd.	1,166	$22.2K	0.00%
GF Fund Management Co. Ltd.	735	$14.3K	0.00%
BNP Paribas Arbitrage, SA	468	$9.07K	0.00%
Daiwa Securities Group Inc.	116	$2.00K	0.00%
Royal Bank of Canada	55	$1.00K	0.00%
Group One Trading, L.P.	23	$446	0.00%
National Bank of Canada	8	$155	0.00%
Aster Capital Management (DIFC) Ltd	5	$97	0.00%

Sold out (5)

Institutions that held Oruka Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ORKA in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Logos Global Management LP	257,330	$6.31M
Cowen and Company, LLC	58,332	$1.43M
ADAR1 Capital Management, LLC	11,187	$274.2K
New England Capital Financial Advisors LLC	41	$1.00K
Danske Bank A/S	2	$49